The instructions for the drug are recommended primarily for the complex therapy of coronary heart disease. Also listed among the indications are chronic heart failure, withdrawal syndrome in chronic alcoholism, decreased performance and physical stress ( including in athletes ).
From the instructions: " usually increased stress on the body leads to a rapid loss of strength, but in the case of using the drug, the body trains to withstand the load, use oxygen economically and quickly restore energy reserves to prepare for new loads ".
World Anti-Doping Agency in 2015 officially tracked the statistical patterns of its use by athletes. Meldonium has been banned since January 1, 2016.
Cardiologists in the Russian Federation often prescribe Mildronate to patients.
Meldonium is a metabolic and antihypoxic drug developed in Latvia and used mainly in the CIS. It prevents disruption of the transport of ATP (the main source of energy) in the cells of the body, dilates blood vessels and improves blood supply to the heart and brain, and improves the contractility of the heart muscle. In this regard, the overall performance of the body increases, and the susceptibility to physical and mental stress decreases. Thus, the intake of meldonium preparations by athletes does not directly increase their physical indicators, but increases their efficiency and makes it easier to endure heavy loads of big sports.
Meldonium is a metabolic agent. To achieve good results, training alone is not enough, you need quality rest. Meldonium helps to recover faster by normalizing cell metabolism after hypoxia (exercise dramatically increases the body's air consumption), stimulates the central nervous system increasing physical performance.
It turns out that the athlete can train more resting less.